GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neovacs SA (XPAR:ALNEV) » Definitions » Deferred Policy Acquisition Costs

Neovacs (XPAR:ALNEV) Deferred Policy Acquisition Costs


View and export this data going back to 2011. Start your Free Trial

What is Neovacs Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Neovacs Business Description

Industry
Traded in Other Exchanges
Address
3-5, Impasse Reille, Paris, FRA, 75014
Neovacs SA is a biotechnology company focused on the development of "Kinoids", therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.